The target of glycemic control:more close to normal level,the better / 中国实用内科杂志

ABSTRACT

In post-trial follow-up of DCCT,UKPDS and Steno-2 studies,sustained beneficial effects on the risk reductions for microvascular and macrovascular complications has been observed in previous intensive treatment group,suggesting that patients with diabetes benefit mostly from early intensive blood glucose control.On the other hand,intensive glucose lowering therapy has been shown to increase the risk of all cause mortality in high-risk patients with type 2 diabetes in ACCORD study.Therefore,the target of blood glucose control should be individualized for each diabetic patient.Not only intensive glucose lowering therapy but also avoidance of hypoglycemia during therapy should be highly considered.